194 related articles for article (PubMed ID: 10022401)
1. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma.
Loh KC; Greenspan FS; Dong F; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1999 Feb; 84(2):458-63. PubMed ID: 10022401
[TBL] [Abstract][Full Text] [Related]
2. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
3. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma.
Kashima K; Yokoyama S; Noguchi S; Murakami N; Yamashita H; Watanabe S; Uchino S; Toda M; Sasaki A; Daa T; Nakayama I
Thyroid; 1998 Mar; 8(3):197-202. PubMed ID: 9545105
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
[TBL] [Abstract][Full Text] [Related]
5. Comparison of T stage, N stage, multifocality, and bilaterality in papillary thyroid carcinoma patients according to the presence of coexisting lymphocytic thyroiditis.
Park JY; Kim DW; Park HK; Ha TK; Jung SJ; Kim DH; Bae SK
Endocr Res; 2015; 40(3):151-5. PubMed ID: 25531396
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
[TBL] [Abstract][Full Text] [Related]
7. The association between chronic lymphocytic thyroiditis and thyroid tumors.
Tamimi DM
Int J Surg Pathol; 2002 Apr; 10(2):141-6. PubMed ID: 12075407
[TBL] [Abstract][Full Text] [Related]
8. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited.
Kebebew E; Treseler PA; Ituarte PH; Clark OH
World J Surg; 2001 May; 25(5):632-7. PubMed ID: 11369991
[TBL] [Abstract][Full Text] [Related]
9. Impact of invasive extranodal extension on the prognosis of patients with papillary thyroid carcinoma.
Moritani S
Thyroid; 2014 Dec; 24(12):1779-83. PubMed ID: 25157399
[TBL] [Abstract][Full Text] [Related]
10. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
11. [Diffuse sclerosing papillary carcinoma of the thyroid gland. Apropos of a pediatric case of association of an unilateral tumor with diffuse lymphocytic thyroiditis].
Rousselet MC; Guyetant S; Croue A; Limal JM; Saint-André JP
Arch Anat Cytol Pathol; 1994; 42(1):10-5. PubMed ID: 8074540
[TBL] [Abstract][Full Text] [Related]
12. Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis.
Kim HS; Choi YJ; Yun JS
Endocr Pathol; 2010 Sep; 21(3):149-53. PubMed ID: 20506003
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
[TBL] [Abstract][Full Text] [Related]
14. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
[TBL] [Abstract][Full Text] [Related]
15. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
16. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of papillary carcinomas of the thyroid gland--retrospective multivariate analysis of 227 patients with median follow-up 130 months].
Kure Y
Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1420-6. PubMed ID: 1448049
[TBL] [Abstract][Full Text] [Related]
18. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults.
Gupta S; Patel A; Folstad A; Fenton C; Dinauer CA; Tuttle RM; Conran R; Francis GL
J Clin Endocrinol Metab; 2001 Mar; 86(3):1346-54. PubMed ID: 11238531
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma.
Leung AK; Chow SM; Law SC
Laryngoscope; 2008 Jan; 118(1):32-8. PubMed ID: 18025951
[TBL] [Abstract][Full Text] [Related]
20. [Differentiated thyroid carcinoma: prognostic factors].
Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
